Surgical Endoscopy

, Volume 26, Issue 12, pp 3515–3520 | Cite as

Laparoscopic Roux-en-Y gastric bypass: long term clinical outcomes

  • Ayman ObeidEmail author
  • Joshua Long
  • Manasi Kakade
  • Ronald H. Clements
  • Richard Stahl
  • Jayleen Grams



Bariatric surgery remains the most effective treatment for morbid obesity, and laparoscopic Roux-en-Y gastric bypass (LRYGB) continues to be the preferred operation. However, data for long-term outcomes are lacking. Our goal was to determine the long-term clinical outcomes after LRYGB.


Retrospective review of a prospectively maintained database was conducted on all patients who underwent LRYGB from 2001–2006. Only patients who had postoperative clinic visits both at ≤2 and ≥5 years were included. Data collected included patient demographics and postoperative clinical outcomes, including percent excess weight loss (%EWL), complications, and improvement or resolution of preoperative comorbidities (type 2 diabetes mellitus, hypertension, obstructive sleep apnea, and hyperlipidemia). Data were analyzed by using SAS (version 9.2) and SPSS (version 16) statistical software.


There were 770 patients who underwent LRYGB at UAB from 2001–2006. Of these, 172 patients met inclusion criteria (148 women and 24 men) with a median age of 41 years and median body mass index of 46 kg/m2. Median short- and long-term follow-up was 12 and 75 months, respectively. Mean %EWL was 69 % for short-term and 65 % for long-term follow-up (P = 0.0032). Of 172 patients, 66 experienced 81 complications at a median of 26 months after operation. The improvement or resolution of comorbidities was maintained in the long-term, and there was no statistically significant difference compared with improvement or resolution in the short-term.


Although there was a statistically significant difference in %EWL between short- and long-term follow-up, both arms showed a clinically relevant %EWL (69 and 65 %) and both were statistically significant compared with preoperative values. The improvement or resolution of comorbidities achieved with LRYGB was maintained in long-term follow-up. Thus, LRYGB resulted in significant improvement in clinical outcomes that were durable in the long term.


Roux-en-Y gastric bypass Outcomes Long-term follow-up Weight loss 



The authors thank Sandre F. McNeal for help with data analysis.


A. Obeid, J. Long, M. Kakade, R.H. Clements, R. Stahl, and J. Grams have no conflict of interest or financial ties to disclose.


  1. 1.
    Wang Y, Beydoun MA (2007) The obesity epidemic in the United States: gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28PubMedCrossRefGoogle Scholar
  2. 2.
    Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497PubMedCrossRefGoogle Scholar
  3. 3.
    Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643PubMedGoogle Scholar
  4. 4.
    Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347:305–313PubMedCrossRefGoogle Scholar
  5. 5.
    Deprés J-P, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881–887CrossRefGoogle Scholar
  6. 6.
    Van Gaal LF, Mertens IL, DeBlock CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880PubMedCrossRefGoogle Scholar
  7. 7.
    Ärnlöv J, Ingelsson E, Sundström J, Lind L (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 131:230–236CrossRefGoogle Scholar
  8. 8.
    Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778PubMedCrossRefGoogle Scholar
  9. 9.
    Freedman DM, Ron E, Ballard-Barbash R, Doody MM, Linet MS (2006) Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes 30:822–829CrossRefGoogle Scholar
  10. 10.
    Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean APH, MacLean LD (2004) Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240:416–423PubMedCrossRefGoogle Scholar
  11. 11.
    Flum DR, Dellinger EP (2004) Impact of gastric bypass operation on survival: a population- based analysis. J Am Coll Surg 199:543–551PubMedCrossRefGoogle Scholar
  12. 12.
    Sjöström L, Narbro K, Sjöström DC, Karason K, Larsson B, Wedel H et al (2007) Effects of bariatric surgery on mortality in swedish obese subjects. N Engl J Med 357:741–752PubMedCrossRefGoogle Scholar
  13. 13.
    Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J (2000) Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232:515–529PubMedCrossRefGoogle Scholar
  14. 14.
    Sjostrom L, Peltonen M, Jacobson P, Sjostrom DC, Karason K, Wedel H et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65PubMedCrossRefGoogle Scholar
  15. 15.
    Deitel M, Gawdat K, Melissas J (2007) Reporting weight loss 2007. Obes Surg 17:565–568PubMedCrossRefGoogle Scholar
  16. 16.
    Scott WR, Batterham RL (2011) Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 301:R15–R27PubMedCrossRefGoogle Scholar
  17. 17.
    Sjöström L (2008) Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes 32:S93–S97CrossRefGoogle Scholar
  18. 18.
    Wolfe BM, Elder KA (2007) Bariatric surgery: review of procedures. Gastroenterology 132:2253–2271PubMedCrossRefGoogle Scholar
  19. 19.
    Pournaras DJ, Aasheim ET, Søvik TT, Andrews R, Mahon D, Welbourn R, Olbers T, le Roux CW (2012) Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Sur 99:110–130CrossRefGoogle Scholar
  20. 20.
    Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S (2012) Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc. doi: 10.1007/s00464-011-2125-z
  21. 21.
    Romy S, Donadini A, Giusti V, Suter M (2012) Roux-en-Y gastric bypass vs gastric banding for morbid obesity: a case-matched study of 442 patients. Arch Surg. doi: 10.1001/archsurg.2011.1708
  22. 22.
    Higa K, Ho T, Tercero F, Yunus T, Boone KB (2011) Laparoscopic roux-en-Y gastric bypass: 10 year follow-up. Surg Obes Relat Dis 7:516–525PubMedCrossRefGoogle Scholar
  23. 23.
    Wittgrove AC, Clark GW (2000) Laparoscopic gastric bypass, Roux-en-Y—500 patients: technique and results, with 3–60 month follow-up. Obes Surg 10:233–239PubMedCrossRefGoogle Scholar
  24. 24.
    Angrisani L, Lorenzo M, Borrelli V (2007) Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 3:127–132PubMedCrossRefGoogle Scholar
  25. 25.
    Suter M, Donadini A, Romy S, Demartines N, Giusti V (2011) Laparoscopic Roux-en-Y gastric bypass significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 254:267–273PubMedCrossRefGoogle Scholar
  26. 26.
    Christou N, Efthimiou E (2009) Five-year outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in a comprehensive bariatric surgery program in Canada. Can J Surg 52:E249–E258PubMedGoogle Scholar
  27. 27.
    Boza C, Gamboa C, Awruch D, Perez G, Escalona A, Ibanez L (2010) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up. Surg Obes Relat Dis 6:470–475PubMedCrossRefGoogle Scholar
  28. 28.
    Boza C, Gamboa C, Salinas J, Achurra P, Vega A, Pérez G (2011) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of follow-up. Surg Obes Relat Dis. doi: 10.1016/j.soard.2011.08.023
  29. 29.
    DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L et al (2010) Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6:249–253PubMedCrossRefGoogle Scholar
  30. 30.
    Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751–758PubMedGoogle Scholar
  31. 31.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2010) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737CrossRefGoogle Scholar
  32. 32.
    Weber M, Müller MK, Bucher T, Wildi S, Dindo D, Horber F, Hauser R, Clavien PA (2004) Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg 240:975–982PubMedCrossRefGoogle Scholar
  33. 33.
    Mognol P, Chosidow D, Marmuse JP (2005) Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding in the super-obese: a comparative study of 290 patients. Obes Surg 15:76–81PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Ayman Obeid
    • 2
    Email author
  • Joshua Long
    • 2
  • Manasi Kakade
    • 2
  • Ronald H. Clements
    • 1
  • Richard Stahl
    • 2
  • Jayleen Grams
    • 2
  1. 1.Department of SurgeryVanderbilt UniversityNashvilleUSA
  2. 2.Department of SurgeryUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations